Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v7-EN
Language English English
Date Updated 2019-11-30 2019-11-29
Drug Identification Number 02382423 02382423
Brand name BICALUTAMIDE BICALUTAMIDE
Common or Proper name BICALUTAMIDE BICALUTAMIDE
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients BICALUTAMIDE BICALUTAMIDE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code L02BB L02BB
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-11-07 2019-11-07
Actual discontinuation date 2019-11-29 2019-11-29
Remaining supply date 2020-01-01 2020-01-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments